Valeant Agrees to Buy Eyetech to Strengthen its Ophthalmology Business

By Heather Cartwright

PharmaDeals Review: Vol 2012 Issue 2 (Table of Contents)

Published: 26 Feb-2012

DOI: 10.3833/pdr.v2012.i2.1688     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

After withdrawing an improved offer to buy ISTA Pharmaceuticals, Valeant Pharmaceuticals has entered into a definitive agreement to acquire Eyetech in order to expand its presence in the ophthalmology market...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: PharmaDeals Ltd

Bookmarks

Bookmark PharmaDeals through one of these social networks.